Drug repurposing
Investigating novel applications for approved medications to accelerate their rapid translation from research to clinical care.
Research
We support high-impact research aimed at identifying and aggressively pursuing molecular, RNA, and genetic-based strategies for treating and curing GRIN2B Disorder.
Strategy
We have adopted a comprehensive research strategy focused on exploring multiple avenues.
Investigating novel applications for approved medications to accelerate their rapid translation from research to clinical care.
We utilize advanced technologies, including human-derived organoids (mini-brains in a dish) and animal models, to better understand the disease and to test both pharmacological and genetic therapies.
Correcting or compensating for the underlying genetic mutation in the GRIN2B gene. This can involve delivering a functional copy of the gene, modulating its expression, or repairing the mutation at the DNA or RNA level, with the goal of restoring normal NMDA receptor function and alleviating the neurological symptoms associated with the disorder.
Portfolio
Published work
Browse the scientific publications produced by our research network to learn how we’re advancing discoveries toward treatments and a cure.